Stroke is the second leading cause of death worldwide and the third leading cause of death
in the USA. A clinically useful biomarker for the diagnosis of stroke does not currently exist …

Background Blood biomarkers are valuable tools for elucidating complex cellular and
molecular mechanisms underlying traumatic brain injury (TBI). Profiling distinct classes of …

Traumatic brain injury (TBI) is a serious problem that causes high morbidity and mortality
around the world. Currently, no reliable biomarkers are used to assess the severity and …

Objective: To investigate the longitudinal evolution of three blood biomarkers: neurofilament
light (NFL), glial fibrillary acidic protein (GFAP) and tau, in out-patients and hospitalized …

Mild traumatic brain injury (mTBI) has a relatively higher incidence in aging people due to
walking problems. Cranial computed tomography and magnetic resonance imaging provide …

Traumatic brain injury (TBI) causes significant neurological deficits and long‐term
degenerative changes. Primary injury in TBI entails distinct neuroanatomical zones, ie …

Recent advances in medicine, intensive care and diagnostic imaging modalities have led to
a pronounced reduction in deaths and disability resulting from traumatic brain injury …

Traumatic brain injuries (TBIs) pose a great health concern. In the United States alone,
nearly 2 million people per year will have suffered a TBI. In the civilian population, most TBIs …

Mild traumatic brain injury (mTBI) is one of the most common neuronal insults and can lead
to long-term disabilities. mTBI occurs when the head is exposed to a rapid acceleration …